Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rifampicin 30.5mg/5ml oral liquid
0501090R0AAAQAQ
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 300mg / Isoniazid 150mg capsules
0501090S0AAADAD
|
Rifampicin/isoniazid | Rifampicin combined preparations | Infections | No data available |
|
Rifampicin 300mg/5ml oral liquid
0501090R0AAAPAP
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 480mg/5ml oral liquid
0501090R0AAARAR
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 600mg inf vials
0501090R0AAADAD
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifater tablets (Imported)
0501090S0BDABAC
|
Rifater | Rifampicin combined preparations | Infections | No data available |
|
Rilpivirine 25mg tablets
0503010AGAAAAAA
|
Rilpivirine | Rilpivirine | Infections | No data available |
|
Rilpivirine 900mg/3ml prolonged-release inj vials
0503010AGAAABAB
|
Rilpivirine | Rilpivirine | Infections | No data available |
|
Rimactane 100mg/5ml syrup
0501090R0BCACAF
|
Rimactane | Rifampicin | Infections | No data available |
|
Rimactane 150mg capsules
0501090R0BCAAAA
|
Rimactane | Rifampicin | Infections | No data available |
|
Rimactazid 150 tablets
0501090S0BCAAAA
|
Rimactazid | Rifampicin combined preparations | Infections | No data available |
|
Rimactazid 300 tablets
0501090S0BCABAB
|
Rimactazid | Rifampicin combined preparations | Infections | No data available |
|
Rimstar tablets
0501090S0BGAAA0
|
Rimstar | Rifampicin combined preparations | Infections | No data available |
|
Ritonavir 100mg capsules
0503010U0AAAAAA
|
Ritonavir | Ritonavir | Infections | No data available |
|
Ritonavir 100mg oral powder sachets sugar free
0503010U0AAADAD
|
Ritonavir | Ritonavir | Infections | No data available |
|
Ritonavir 80mg/1ml oral solution sugar free
0503010U0AAABAB
|
Ritonavir | Ritonavir | Infections | No data available |
|
Rommix 250 EC tablets
0501050C0BIAAAB
|
Rommix (Tablet) | Erythromycin | Infections | No data available |
|
Rukobia 600mg modified-release tablets
0503010AXBBAAAA
|
Rukobia | Fostemsavir | Infections | No data available |
|
Saquinavir mesilate 200mg capsules
0503010R0AAAAAA
|
Saquinavir mesylate | Saquinavir mesylate | Infections | No data available |
|
Saquinavir mesilate 500mg tablets
0503010R0AAABAB
|
Saquinavir mesylate | Saquinavir mesylate | Infections | No data available |
|
Sebivo 600mg tablets
0503031C0BBAAAA
|
Sebivo | Telbivudine | Infections | No data available |
|
Sebomin MR 100mg capsules
0501030P0BGAAAC
|
Sebomin | Minocycline hydrochloride | Infections | No data available |
|
Sebren MR 100mg capsules
0501030P0BIAAAC
|
Sebren | Minocycline hydrochloride | Infections | No data available |
|
Septrin Adult 80mg/400mg/5ml oral suspension
0501080D0BGAEAE
|
Septrin | Co-trimoxazole(Trimethoprim/sulfamethoxazole) | Infections | No data available |
|
Septrin for Infusion 80mg/400mg/5ml inf ampoules
0501080D0BGAHAB
|
Septrin | Co-trimoxazole(Trimethoprim/sulfamethoxazole) | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.